In this work, low (<20 MBq) doses of 89Zr-Df-Crefmirlimab tracer were used with the 194-cm-long uEXPLORER total-body PET scanner to study the biodistribution and kinetics of CD8+ cells in COVID-19 convalescent patients and in healthy controls. This evidence concerns the gene CD8A and COVID-19.